A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer

Clinical trial NCT00539383 · COMPLETED

Trial details

NCT number: NCT00539383
Sponsor: Angiochem Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors With and Without Brain Metastases

Start date: 2007-10-01
Primary completion: 2010-03-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.